Status: current, Primitive. Date: 28-Feb 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4672111000168117 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen (AU substance) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4672121000168112 | SARS-CoV-2 rS (NVX-CoV2373) antigen | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4673941000168111 | severe acute respiratory syndrome coronavirus-2 recombinant spike protein (NVX-CoV2373) antigen | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| SARS-CoV-2 rS (NVX-CoV2373) antigen | Is a | medicinal substance | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nuvaxovid Multidose injection, 5 mL vial | has Australian BoSS | True | SARS-CoV-2 rS (NVX-CoV2373) antigen | Inferred relationship | Some | 1348490260 |
| Nuvaxovid Multidose injection, 5 mL vial | has intended active ingredient | True | SARS-CoV-2 rS (NVX-CoV2373) antigen | Inferred relationship | Some | 1348490260 |
| COVID-19 (NVX-CoV2373) vaccine | has intended active ingredient | True | SARS-CoV-2 rS (NVX-CoV2373) antigen | Inferred relationship | Some | 1052506438 |
| COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial | has intended active ingredient | True | SARS-CoV-2 rS (NVX-CoV2373) antigen | Inferred relationship | Some | 926575644 |
| COVID-19 (NVX-CoV2373) vaccine injection, 5 mL vial | has Australian BoSS | True | SARS-CoV-2 rS (NVX-CoV2373) antigen | Inferred relationship | Some | 926575644 |
This concept is not in any reference sets
FHIR